10 completed, 9 unknown, 6 not yet recruiting, 4 recruiting. 8 Phase 2, 6 Not applicable, 4 Phase 1, 4 Phase 3, 3 Phase 4.
Follow Diabetic Nephropathy Type 2: new trials by email Literature Review of Diabetic Nephropathy Type 2 trials Research Report on Diabetic Nephropathy Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Beta-2-Trace Protein in Diabetic Nephropathy Diabetic Nephropathy Type 2, Type 2 Diabetes Mellitus | Not yet recruiting | Assiut University | 80 | 2026-11-10 | 2026-11-05 | |
| Vitamin D in Diabetic Neuropathy Vitamin D - Diabetic Nephropathy Type 2 | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 150 | 2026-10-01 | 2026-09-08 |
| Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy Human umbilical cord mesenchymal stem cell injection - Diabetic Nephropathy Type 2 | Phase 1 / Phase 2 | Not yet recruiting | The First People's Hospital of Changzhou | 49 | 2026-09-01 | 2026-08-18 |
| Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial Umbilical Cord Mesenchymal Stem Cells - Diabetic Nephropathy Type 2 | Phase 1 / Phase 2 | Recruiting | PT. Prodia Stem Cell Indonesia | 10 | 2026-07-01 | 2026-02-09 |
| Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence Jiajian Yishen Xiaozheng Qufeng Granules - Diabetic Nephropathy Type 2, Chronic Renal Failure/ Kidney Disease | Not applicable | Not yet recruiting | Jiazhen Yin | 198 | 2026-03-12 | 2026-03-10 |
| Relationship of Serum Zinc Level With Severity of Diabetic Nephropathy Diabetic Nephropathy Type 2 | Not yet recruiting | Assiut University | 92 | 2025-12-01 | 2024-11-15 | |
| Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes Polygenic Risk Score - Diabetes Mellitus, Type 2, Cardiovascular Diseases | Not applicable | Recruiting | Optithera | 2714 | 2024-08-23 | 2024-09-19 |
| Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status clinical periodontal measurements, serum samples, saliva samples - Diabetic Nephropathy Type 2, Type 2 Diabetes | Completed | Pamukkale University | 126 | 2024-06-10 | 2026-03-27 | |
| Effect of Exercise Therapy on Type II Diabetic Neuropathic Patients Experimental group 1 :Ball training, Experimental group 2 :Frenkel Exercises, Control Group - Diabetic Nephropathy Type 2 | Not applicable | Completed | Dr. Sobia Hasan | 90 | 2024-05-05 | 2024-12-31 |
| Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study. Dorzagliatin, Gliclazide - Diabetic Nephropathy Type 2 | Not applicable | Unknown | Yan Bi | 106 | 2024-02-20 | 2024-01-24 |
| Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy Acetylsalicylic Acid, Placebo - Diabetic Nephropathy Type 2 | Phase 2 / Phase 3 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 355 | 2024-01-01 | 2023-10-05 |
| Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease Empagliflozin 25 MG, Enalapril Maleate 20 mg - Diabetic Nephropathy Type 2 | Phase 2 / Phase 3 | Unknown | Omar Tarek Elfarargi | 212 | 2023-03-01 | 2022-05-13 |
| Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy Diabetic Nephropathy Type 2, Diabetic Kidney Disease | Recruiting | Chinese PLA General Hospital | 2000 | 2022-08-01 | 2023-06-05 | |
| Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients Dapagliflozin - Diabetic Nephropathy Type 2 | Phase 4 | Completed | Mohammed Mahmood Mohammed | 40 | 2022-05-01 | 2024-03-22 |
| Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease Diabetic Nephropathy Type 2, Type 2 Diabetes Mellitus (T2DM) | Completed | The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine | 556 | 2022-04-18 | 2026-08-12 | |
| Investigational and Comparative Study in the Management of Diabetic Nephropathy Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet - Diabetic Nephropathy Type 2 | Phase 3 | Completed | Tanta University | 90 | 2022-02-01 | 2024-05-14 |
| Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy Enzyme linked immunosorbent assay - Diabetic Nephropathy Type 2 | Unknown | Zheng Guo | 180 | 2021-08-01 | 2021-07-15 | |
| Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics. Diabetic Nephropathy Type 2, Biomarker | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 1000 | 2021-05-01 | 2021-07-20 | |
| Atrasentan in Patients With Proteinuric Glomerular Diseases Atrasentan - IgA Nephropathy, Focal Segmental Glomerulosclerosis | Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 103 | 2021-03-15 | 2026-06-01 |
| Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy Sleep Apnea, Diabetic Nephropathy Type 2 | Completed | University of Aarhus | 74 | 2020-10-01 | 2022-02-07 |
Showing 20 of 32. Sign in to see all of them.
Diabetic Nephropathies (10) · Diabetes Mellitus, Type 2 (8) · Kidney Diseases (3) · Renal Insufficiency, Chronic (3) · Albuminuria (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Diabetic Neuropathies (1) · Disease (1) · Genetic Risk Score (1) · Gingivitis (1) · Glomerulonephritis, IGA (1) · Glomerulosclerosis, Focal Segmental (1)
Endocrine System Diseases (14) · Diabetes Mellitus (13) · Female Urogenital Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (13) · Male Urogenital Diseases (13) · Urogenital Diseases (13) · Urologic Diseases (13) · Diabetes Complications (11) · Kidney Diseases (10) · Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Glucose Metabolism Disorders (8) · Pathological Conditions, Signs and Symptoms (7) · Pathologic Processes (5) · Disease Attributes (4)
Enalapril (2) · empagliflozin (2) · Asian ginseng (1) · Aspirin (1) · Atrasentan (1) · Clinical Laboratory Techniques (1) · Continuous Glucose Monitoring (1) · Control Groups (1) · Dorzagliatin (1) · Eplerenone (1) · Gestyl (1) · Gliclazide (1) · Linagliptin (1) · Lisinopril (1) · Losartan (1)
Assiut University (3) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Shanghai University of Traditional Chinese Medicine (2) · Tanta University (2) · Beni-Suef University (1) · Centro Universitario de Ciencias de la Salud, Mexico (1) · Chang Gung Memorial Hospital (1) · Chinese PLA General Hospital (1) · Copenhagen University Hospital, Rigshospitalet (1) · Dr. Sobia Hasan (1) · James A. Tumlin, MD (1) · Jiazhen Yin (1) · Leiden University Medical Center (1) · Mayo Clinic (1) · Mohammed Mahmood Mohammed (1)
China (7) · Denmark (3) · United States (3) · Egypt (2) · Italy (2) · Australia (1) · Canada (1) · Indonesia (1) · Iraq (1) · Mexico (1) · Netherlands (1) · Pakistan (1) · South Korea (1) · Spain (1) · Taiwan (1)
Yueyi Deng, PhD (2) · Aftab Ahmed Mirza Baig, PhD (1) · Chao Zheng, MD,PhD (1) · Dina A Mohammed, prof (1) · Jakob T. Nyvad, MD (1) · Juan Huang, Doctor (1) · LaTonya J Hickson, MD (1) · Mostafa O El Mokadem, M.D. (1) · Niels H. Buus, MD PhD DMSc (1) · Omar T Elfarargi (1) · Pavel Hamet, MD, PhD (1) · Rong Yu, Doctor (1) · Sebastian Nielsen, MD student (1) · Sobia Hasan, PhD* (1)
PMID 32848436, PMID 33131308, PMID 34533892, PMID 34788550, PMID 34940288, PMID 37254256, PMID 38600065, PMID 38915115, PMID 39228893, PMID 39899371, PMID 40938675, PMID 41141513, PMID 41442197